Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
Multiple sclerosis is a complex, autoimmune-mediated disease of the central nervous
system characterized by inflammatory demyelination and axonal/neuronal damage. The …
system characterized by inflammatory demyelination and axonal/neuronal damage. The …
[HTML][HTML] Pregnancy and multiple sclerosis: an update
G Varytė, A Arlauskienė… - Current Opinion in …, 2021 - journals.lww.com
Pregnancy and multiple sclerosis: an update : Current Opinion in Obstetrics and Gynecology
Pregnancy and multiple sclerosis: an update : Current Opinion in Obstetrics and Gynecology …
Pregnancy and multiple sclerosis: an update : Current Opinion in Obstetrics and Gynecology …
[HTML][HTML] Interferons and multiple sclerosis: Lessons from 25 years of clinical and real-world experience with intramuscular interferon beta-1a (Avonex)
SL Cohan, BA Hendin, AT Reder, K Smoot, R Avila… - CNS drugs, 2021 - Springer
Abstract Recombinant interferon (IFN) β-1b was approved by the US Food and Drug
Administration as the first disease-modifying therapy (DMT) for multiple sclerosis (MS) in …
Administration as the first disease-modifying therapy (DMT) for multiple sclerosis (MS) in …
Use of disease-modifying drugs during pregnancy and breastfeeding
Use of disease-modifying drugs during pregnancy and breastfe... : Current Opinion in
Neurology Use of disease-modifying drugs during pregnancy and breastfeeding : Current …
Neurology Use of disease-modifying drugs during pregnancy and breastfeeding : Current …
Pregnancy outcomes after early fetal exposure to injectable first‐line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis
JB Andersen, F Sellebjerg… - European Journal of …, 2023 - Wiley Online Library
Background and purpose Data on pregnancy outcomes following fetal exposure to disease‐
modifying drugs (DMDs) in women with multiple sclerosis (MS) are sparse although …
modifying drugs (DMDs) in women with multiple sclerosis (MS) are sparse although …
Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study
K Fink, A Gorczyca, P Alping… - Multiple Sclerosis …, 2023 - journals.sagepub.com
Background: There is a paucity of information on maternal multiple sclerosis (MS) and risk of
adverse pregnancy and perinatal outcomes. Objective: The aim of this study was to …
adverse pregnancy and perinatal outcomes. Objective: The aim of this study was to …
Updated perspectives on the challenges of managing multiple sclerosis during pregnancy
R Villaverde-González - Degenerative Neurological and …, 2022 - Taylor & Francis
Multiple sclerosis (MS) is a chronic immune-mediated, inflammatory, and degenerative
disease that is up to three times more frequent in young women. MS does not alter fertility …
disease that is up to three times more frequent in young women. MS does not alter fertility …
Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation
Introduction Interferon beta (IFN beta) preparations are an established group of drugs used
for immunomodulation in patients with multiple sclerosis (MS). Subcutaneously (sc) applied …
for immunomodulation in patients with multiple sclerosis (MS). Subcutaneously (sc) applied …
[HTML][HTML] Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper)
Abstract Die Multiple Sklerose ist eine komplexe, autoimmun vermittelte Erkrankung des
zentralen Nervensystems, charakterisiert durch inflammatorische Demyelinisierung sowie …
zentralen Nervensystems, charakterisiert durch inflammatorische Demyelinisierung sowie …
[HTML][HTML] Maternal Multiple Sclerosis and Offspring's Cognitive and Behavioral Development: What Do We Know until Now?
M Siracusano, E Carloni, A Riccioni, M Ferrara… - Children, 2022 - mdpi.com
Multiple Sclerosis (MS) is a chronic pathological condition representing one of the main
causes of neurological disability in the female young population. MS, as an immune …
causes of neurological disability in the female young population. MS, as an immune …